Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial-Reference-Cited by-同舟云学术

Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial

Published:2017-08 Issue: Volume:218 Page:277-283
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Murrough James W.,Wade Elizabeth,Sayed Sehrish,Ahle Gabriella,Kiraly Drew D.,Welch Alison,Collins Katherine A.,Soleimani Laili,Iosifescu Dan V.,Charney Dennis S.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference52 articles.

1. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics;Abdallah;Annu. Rev. Med.,2015

2. Scale for suicide ideation: psychometric properties of a self-report version;Beck;J. Clin. Psychol.,1988

3. New approaches to antidepressant drug discovery: beyond monoamines;Berton;Nat. Rev. Neurosci.,2006

4. Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS);Bremner;J. Trauma. Stress.,1998

5. Ketamine and other glutamate receptor modulators for depression in adults;Caddy;Cochrane Database Syst. Rev.,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics;Molecular Biology Reports;2024-01-28

2. Maintenance of antidepressant effect by dextromethorphan in patients with treatment-resistant depression who respond to ketamine intervention;Medical Hypotheses;2024-01

3. Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression;Pharmaceuticals;2023-11-07

4. An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression;Journal of Clinical Psychopharmacology;2023-07-26

5. Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence;Expert Review of Neurotherapeutics;2023-03-04